Fusion Gene Studies
in Kim Lab

FusionBase FusionGDB FusionGDB2 FusionPDB FusionNeoAntigen FusionAI FusionNW FGviewer Publication Contact
FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact
Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:ATRX-BCL2 (FusionGDB2 ID:HG546TG596)

Fusion Gene Summary for ATRX-BCL2

check button Fusion gene summary
Fusion gene informationFusion gene name: ATRX-BCL2
Fusion gene ID: hg546tg596
HgeneTgene
Gene symbol

ATRX

BCL2

Gene ID

546

596

Gene nameATRX chromatin remodelerBCL2 apoptosis regulator
SynonymsJMS|MRX52|RAD54|RAD54L|XH2|XNP|ZNF-HXBcl-2|PPP1R50
Cytomap('ATRX')('BCL2')

Xq21.1

18q21.33

Type of geneprotein-codingprotein-coding
Descriptiontranscriptional regulator ATRXATP-dependent helicase ATRXX-linked helicase IIX-linked nuclear proteinalpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)apoptosis regulator Bcl-2B-cell CLL/lymphoma 2protein phosphatase 1, regulatory subunit 50
Modification date2020031320200329
UniProtAcc.

P10415

Ensembl transtripts involved in fusion geneENST00000373344, ENST00000395603, 
ENST00000480283, ENST00000373341, 
Fusion gene scores* DoF score17 X 13 X 9=19895 X 3 X 4=60
# samples 236
** MAII scorelog2(23/1989*10)=-3.11233750988937
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0		log2(6/60*10)=0
Context

PubMed: ATRX [Title/Abstract] AND BCL2 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointATRX(77041468)-BCL2(60795992), # samples:3
Anticipated loss of major functional domain due to fusion event.ATRX-BCL2 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF.
ATRX-BCL2 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF.
ATRX-BCL2 seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF.
ATRX-BCL2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF.
ATRX-BCL2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneATRX

GO:0006334

nucleosome assembly

20651253

HgeneATRX

GO:0006338

chromatin remodeling

20651253

TgeneBCL2

GO:0000209

protein polyubiquitination

16717086

TgeneBCL2

GO:0006915

apoptotic process

36599|8022822

TgeneBCL2

GO:0008625

extrinsic apoptotic signaling pathway via death domain receptors

10597216

TgeneBCL2

GO:0009636

response to toxic substance

16307838|16717086

TgeneBCL2

GO:0010039

response to iron ion

11264898

TgeneBCL2

GO:0022898

regulation of transmembrane transporter activity

9219694

TgeneBCL2

GO:0030307

positive regulation of cell growth

8022822

TgeneBCL2

GO:0032848

negative regulation of cellular pH reduction

10506221

TgeneBCL2

GO:0034097

response to cytokine

9184696

TgeneBCL2

GO:0035094

response to nicotine

12421819

TgeneBCL2

GO:0042100

B cell proliferation

1373874

TgeneBCL2

GO:0042493

response to drug

36599

TgeneBCL2

GO:0043066

negative regulation of apoptotic process

1373874|7650367|7772249|8050499|8080725|9027314|9219694|10506221|10620603|15776018|20041405

TgeneBCL2

GO:0043524

negative regulation of neuron apoptotic process

7546744

TgeneBCL2

GO:0051607

defense response to virus

10620603

TgeneBCL2

GO:0051924

regulation of calcium ion transport

8022822

TgeneBCL2

GO:0070059

intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress

15776018

TgeneBCL2

GO:2001243

negative regulation of intrinsic apoptotic signaling pathway

11684014



check button Fusion gene information
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4LGGTCGA-DB-A4XF-01AATRXchrX

77041468

-BCL2chr18

60795992

-
ChimerDB4LGGTCGA-DB-A4XFATRXchrX

77041467

-BCL2chr18

60795992

-
ChimerDB4LGGTCGA-DB-A4XFATRXchrX

77041468

-BCL2chr18

60795992

-


Top

Fusion Gene ORF analysis for ATRX-BCL2

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
5CDS-5UTRENST00000373344ENST00000590515ATRXchrX

77041468

-BCL2chr18

60795992

-
5CDS-5UTRENST00000373344ENST00000590515ATRXchrX

77041467

-BCL2chr18

60795992

-
5CDS-5UTRENST00000395603ENST00000590515ATRXchrX

77041468

-BCL2chr18

60795992

-
5CDS-5UTRENST00000395603ENST00000590515ATRXchrX

77041467

-BCL2chr18

60795992

-
5CDS-intronENST00000373344ENST00000444484ATRXchrX

77041468

-BCL2chr18

60795992

-
5CDS-intronENST00000373344ENST00000444484ATRXchrX

77041467

-BCL2chr18

60795992

-
5CDS-intronENST00000373344ENST00000589955ATRXchrX

77041468

-BCL2chr18

60795992

-
5CDS-intronENST00000373344ENST00000589955ATRXchrX

77041467

-BCL2chr18

60795992

-
5CDS-intronENST00000395603ENST00000444484ATRXchrX

77041468

-BCL2chr18

60795992

-
5CDS-intronENST00000395603ENST00000444484ATRXchrX

77041467

-BCL2chr18

60795992

-
5CDS-intronENST00000395603ENST00000589955ATRXchrX

77041468

-BCL2chr18

60795992

-
5CDS-intronENST00000395603ENST00000589955ATRXchrX

77041467

-BCL2chr18

60795992

-
5UTR-3CDSENST00000480283ENST00000333681ATRXchrX

77041468

-BCL2chr18

60795992

-
5UTR-3CDSENST00000480283ENST00000333681ATRXchrX

77041467

-BCL2chr18

60795992

-
5UTR-3CDSENST00000480283ENST00000398117ATRXchrX

77041468

-BCL2chr18

60795992

-
5UTR-3CDSENST00000480283ENST00000398117ATRXchrX

77041467

-BCL2chr18

60795992

-
5UTR-5UTRENST00000480283ENST00000590515ATRXchrX

77041468

-BCL2chr18

60795992

-
5UTR-5UTRENST00000480283ENST00000590515ATRXchrX

77041467

-BCL2chr18

60795992

-
5UTR-intronENST00000480283ENST00000444484ATRXchrX

77041468

-BCL2chr18

60795992

-
5UTR-intronENST00000480283ENST00000444484ATRXchrX

77041467

-BCL2chr18

60795992

-
5UTR-intronENST00000480283ENST00000589955ATRXchrX

77041468

-BCL2chr18

60795992

-
5UTR-intronENST00000480283ENST00000589955ATRXchrX

77041467

-BCL2chr18

60795992

-
Frame-shiftENST00000373344ENST00000333681ATRXchrX

77041468

-BCL2chr18

60795992

-
Frame-shiftENST00000373344ENST00000333681ATRXchrX

77041467

-BCL2chr18

60795992

-
Frame-shiftENST00000373344ENST00000398117ATRXchrX

77041468

-BCL2chr18

60795992

-
Frame-shiftENST00000373344ENST00000398117ATRXchrX

77041467

-BCL2chr18

60795992

-
Frame-shiftENST00000395603ENST00000333681ATRXchrX

77041468

-BCL2chr18

60795992

-
Frame-shiftENST00000395603ENST00000333681ATRXchrX

77041467

-BCL2chr18

60795992

-
Frame-shiftENST00000395603ENST00000398117ATRXchrX

77041468

-BCL2chr18

60795992

-
Frame-shiftENST00000395603ENST00000398117ATRXchrX

77041467

-BCL2chr18

60795992

-
intron-3CDSENST00000373341ENST00000333681ATRXchrX

77041468

-BCL2chr18

60795992

-
intron-3CDSENST00000373341ENST00000333681ATRXchrX

77041467

-BCL2chr18

60795992

-
intron-3CDSENST00000373341ENST00000398117ATRXchrX

77041468

-BCL2chr18

60795992

-
intron-3CDSENST00000373341ENST00000398117ATRXchrX

77041467

-BCL2chr18

60795992

-
intron-5UTRENST00000373341ENST00000590515ATRXchrX

77041468

-BCL2chr18

60795992

-
intron-5UTRENST00000373341ENST00000590515ATRXchrX

77041467

-BCL2chr18

60795992

-
intron-intronENST00000373341ENST00000444484ATRXchrX

77041468

-BCL2chr18

60795992

-
intron-intronENST00000373341ENST00000444484ATRXchrX

77041467

-BCL2chr18

60795992

-
intron-intronENST00000373341ENST00000589955ATRXchrX

77041468

-BCL2chr18

60795992

-
intron-intronENST00000373341ENST00000589955ATRXchrX

77041467

-BCL2chr18

60795992

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)		BP loci
(transcript)		Predicted start
(transcript)		Predicted stop
(transcript)		Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for ATRX-BCL2


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)


Top

Fusion Protein Features for ATRX-BCL2


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:77041468/:60795992)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
.BCL2

P10415

FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.FUNCTION: Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed:17418785). {ECO:0000269|PubMed:17418785, ECO:0000269|PubMed:18570871}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for ATRX-BCL2


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for ATRX-BCL2


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for ATRX-BCL2


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status
TgeneBCL2P10415DB01050IbuprofenModulatorSmall moleculeApproved
TgeneBCL2P10415DB01367RasagilineActivatorSmall moleculeApproved
TgeneBCL2P10415DB01248DocetaxelSmall moleculeApproved|Investigational
TgeneBCL2P10415DB08871EribulinSmall moleculeApproved|Investigational
TgeneBCL2P10415DB09213DexibuprofenNegative modulatorSmall moleculeApproved|Investigational
TgeneBCL2P10415DB09401IsosorbideSmall moleculeApproved|Investigational
TgeneBCL2P10415DB11581VenetoclaxInhibitorSmall moleculeApproved|Investigational
TgeneBCL2P10415DB06756Glycine betaineSmall moleculeApproved|Nutraceutical
TgeneBCL2P10415DB01229PaclitaxelInhibitorSmall moleculeApproved|Vet_approved

Top

Related Diseases for ATRX-BCL2


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneATRXC0796003Juberg-Marsidi syndrome17CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
HgeneATRXC1845055ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED16CTD_human;GENOMICS_ENGLAND;UNIPROT
HgeneATRXC0017638Glioma2CTD_human
HgeneATRXC0027819Neuroblastoma2CTD_human
HgeneATRXC0259783mixed gliomas2CTD_human
HgeneATRXC0555198Malignant Glioma2CTD_human
HgeneATRXC0010417Cryptorchidism1CTD_human
HgeneATRXC0010606Adenoid Cystic Carcinoma1CTD_human
HgeneATRXC0018273Growth Disorders1CTD_human
HgeneATRXC0030297Pancreatic Neoplasm1CTD_human
HgeneATRXC0030846Penile Diseases1CTD_human
HgeneATRXC0039978Thoracic Diseases1CTD_human
HgeneATRXC0206754Neuroendocrine Tumors1CTD_human
HgeneATRXC0346647Malignant neoplasm of pancreas1CTD_human
HgeneATRXC0376634Craniofacial Abnormalities1CTD_human
HgeneATRXC0431663Bilateral Cryptorchidism1CTD_human
HgeneATRXC0431664Unilateral Cryptorchidism1CTD_human
HgeneATRXC0585216Alpha-Thalassemia Myelodysplasia Syndrome1CTD_human;GENOMICS_ENGLAND;ORPHANET
HgeneATRXC0796159Mental retardation Smith Fineman Myers type1ORPHANET
HgeneATRXC1136249Mental Retardation, X-Linked1CTD_human
HgeneATRXC1563730Abdominal Cryptorchidism1CTD_human
HgeneATRXC1563731Inguinal Cryptorchidism1CTD_human
HgeneATRXC2713368Hematopoetic Myelodysplasia1CTD_human
HgeneATRXC3463824MYELODYSPLASTIC SYNDROME1CTD_human
TgeneC0011581Depressive disorder5PSYGENET
TgeneC0024301Lymphoma, Follicular4CTD_human;ORPHANET
TgeneC0005586Bipolar Disorder3PSYGENET
TgeneC0006142Malignant neoplasm of breast3CTD_human
TgeneC0007102Malignant tumor of colon3CTD_human
TgeneC0007621Neoplastic Cell Transformation3CTD_human
TgeneC0009375Colonic Neoplasms3CTD_human
TgeneC0678222Breast Carcinoma3CTD_human
TgeneC1257931Mammary Neoplasms, Human3CTD_human
TgeneC1458155Mammary Neoplasms3CTD_human
TgeneC4704874Mammary Carcinoma, Human3CTD_human
TgeneC0001430Adenoma2CTD_human
TgeneC0002152Alloxan Diabetes2CTD_human
TgeneC0004352Autistic Disorder2CTD_human
TgeneC0011853Diabetes Mellitus, Experimental2CTD_human
TgeneC0015923Fetal Alcohol Syndrome2PSYGENET
TgeneC0019207Hepatoma, Morris2CTD_human
TgeneC0019208Hepatoma, Novikoff2CTD_human
TgeneC0023434Chronic Lymphocytic Leukemia2CTD_human
TgeneC0023904Liver Neoplasms, Experimental2CTD_human
TgeneC0024302Reticulosarcoma2CTD_human
TgeneC0024304Lymphoma, Mixed-Cell2CTD_human
TgeneC0024305Lymphoma, Non-Hodgkin2CTD_human;UNIPROT
TgeneC0024306Lymphoma, Undifferentiated2CTD_human
TgeneC0027540Necrosis2CTD_human
TgeneC0027746Nerve Degeneration2CTD_human
TgeneC0036341Schizophrenia2PSYGENET
TgeneC0038433Streptozotocin Diabetes2CTD_human
TgeneC0079740High Grade Lymphoma (neoplasm)2CTD_human
TgeneC0079741Lymphoma, Intermediate-Grade2CTD_human
TgeneC0079745Lymphoma, Large-Cell, Follicular2CTD_human
TgeneC0079747Low Grade Lymphoma (neoplasm)2CTD_human
TgeneC0079757Diffuse Mixed-Cell Lymphoma2CTD_human
TgeneC0079758Lymphoma, Mixed-Cell, Follicular2CTD_human
TgeneC0079765Lymphoma, Small Cleaved-Cell, Follicular2CTD_human
TgeneC0079770Lymphoma, Small Noncleaved-Cell2CTD_human
TgeneC0086404Experimental Hepatoma2CTD_human
TgeneC0205646Adenoma, Basal Cell2CTD_human
TgeneC0205647Follicular adenoma2CTD_human
TgeneC0205648Adenoma, Microcystic2CTD_human
TgeneC0205649Adenoma, Monomorphic2CTD_human
TgeneC0205650Papillary adenoma2CTD_human
TgeneC0205651Adenoma, Trabecular2CTD_human
TgeneC0235874Disease Exacerbation2CTD_human
TgeneC0853193Bipolar I disorder2PSYGENET
TgeneC1956130Lymphoma, Follicular, Grade 12CTD_human
TgeneC1956131Lymphoma, Follicular, Grade 32CTD_human
TgeneC1956132Lymphoma, Follicular, Grade 22CTD_human
TgeneC3714542Lymphoma, Diffuse2CTD_human
TgeneC4721532Lymphoma, Non-Hodgkin, Familial2CTD_human
TgeneC0001418Adenocarcinoma1CTD_human
TgeneC0002395Alzheimer's Disease1CTD_human
TgeneC0004096Asthma1CTD_human
TgeneC0004509Azoospermia1CTD_human
TgeneC0007097Carcinoma1CTD_human
TgeneC0009402Colorectal Carcinoma1CTD_human
TgeneC0009404Colorectal Neoplasms1CTD_human
TgeneC0011265Presenile dementia1CTD_human
TgeneC0011616Contact Dermatitis1CTD_human
TgeneC0011860Diabetes Mellitus, Non-Insulin-Dependent1CTD_human
TgeneC0013366Dyschondroplasias1CTD_human
TgeneC0014859Esophageal Neoplasms1CTD_human
TgeneC0016978gallbladder neoplasm1CTD_human
TgeneC0018671Head and Neck Neoplasms1CTD_human
TgeneC0018675Head Neoplasms1CTD_human
TgeneC0020538Hypertensive disease1CTD_human
TgeneC0021364Male infertility1CTD_human
TgeneC0021841Intestinal Neoplasms1CTD_human
TgeneC0023186Learning Disorders1CTD_human
TgeneC0023467Leukemia, Myelocytic, Acute1CTD_human
TgeneC0023891Liver Cirrhosis, Alcoholic1CTD_human
TgeneC0025237Melnick-Needles Syndrome1CTD_human
TgeneC0025261Memory Disorders1CTD_human
TgeneC0025568Metaplasia1CTD_human
TgeneC0026760Multiple Epiphyseal Dysplasia1CTD_human
TgeneC0026764Multiple Myeloma1CTD_human
TgeneC0026998Acute Myeloid Leukemia, M11CTD_human
TgeneC0027051Myocardial Infarction1CTD_human
TgeneC0027533Neck Neoplasms1CTD_human
TgeneC0029422Osteochondrodysplasias1CTD_human
TgeneC0032460Polycystic Ovary Syndrome1CTD_human
TgeneC0033578Prostatic Neoplasms1CTD_human
TgeneC0035126Reperfusion Injury1CTD_human
TgeneC0035304Retinal Degeneration1CTD_human
TgeneC0036391Schwartz-Jampel Syndrome1CTD_human
TgeneC0037579Soft Tissue Neoplasms1CTD_human
TgeneC0038015Spondyloepiphyseal Dysplasia1CTD_human
TgeneC0039101synovial sarcoma1CTD_human
TgeneC0079744Diffuse Large B-Cell Lymphoma1CTD_human
TgeneC0153452Malignant neoplasm of gallbladder1CTD_human
TgeneC0162351Contact hypersensitivity1CTD_human
TgeneC0162820Dermatitis, Allergic Contact1CTD_human
TgeneC0205641Adenocarcinoma, Basal Cell1CTD_human
TgeneC0205642Adenocarcinoma, Oxyphilic1CTD_human
TgeneC0205643Carcinoma, Cribriform1CTD_human
TgeneC0205644Carcinoma, Granular Cell1CTD_human
TgeneC0205645Adenocarcinoma, Tubular1CTD_human
TgeneC0205696Anaplastic carcinoma1CTD_human
TgeneC0205697Carcinoma, Spindle-Cell1CTD_human
TgeneC0205698Undifferentiated carcinoma1CTD_human
TgeneC0205699Carcinomatosis1CTD_human
TgeneC0206637Mesenchymal Chondrosarcoma1CTD_human
TgeneC0206681Adenocarcinoma, Clear Cell1CTD_human
TgeneC0233794Memory impairment1CTD_human
TgeneC0242350Erectile dysfunction1CTD_human
TgeneC0276496Familial Alzheimer Disease (FAD)1CTD_human
TgeneC0276535AIDS with Kaposi's sarcoma1CTD_human
TgeneC0278996Malignant Head and Neck Neoplasm1CTD_human
TgeneC0334660Angioendotheliomatosis1ORPHANET
TgeneC0345967Malignant mesothelioma1CTD_human
TgeneC0346627Intestinal Cancer1CTD_human
TgeneC0376358Malignant neoplasm of prostate1CTD_human
TgeneC0432272Van Buchem disease1CTD_human
TgeneC0494463Alzheimer Disease, Late Onset1CTD_human
TgeneC0546126Acute Confusional Senile Dementia1CTD_human
TgeneC0546837Malignant neoplasm of esophagus1CTD_human
TgeneC0746787Cancer of Neck1CTD_human
TgeneC0750900Alzheimer's Disease, Focal Onset1CTD_human
TgeneC0750901Alzheimer Disease, Early Onset1CTD_human
TgeneC0751177Cancer of Head1CTD_human
TgeneC0751262Adult Learning Disorders1CTD_human
TgeneC0751263Learning Disturbance1CTD_human
TgeneC0751265Learning Disabilities1CTD_human
TgeneC0751292Age-Related Memory Disorders1CTD_human
TgeneC0751293Memory Disorder, Semantic1CTD_human
TgeneC0751294Memory Disorder, Spatial1CTD_human
TgeneC0751295Memory Loss1CTD_human
TgeneC0848676Subfertility, Male1CTD_human
TgeneC0887900Upper Aerodigestive Tract Neoplasms1CTD_human
TgeneC0917731Male sterility1CTD_human
TgeneC1136382Sclerocystic Ovaries1CTD_human
TgeneC1330966Developmental Academic Disorder1CTD_human
TgeneC1879321Acute Myeloid Leukemia (AML-M2)1CTD_human
TgeneC1961099Precursor T-Cell Lymphoblastic Leukemia-Lymphoma1CTD_human
TgeneC2931456Prostate cancer, familial1CTD_human
TgeneC2937358Cerebral Hemorrhage1CTD_human
TgeneC2985290Fetal Alcohol Spectrum Disorders1PSYGENET
TgeneC3541456Spondyloepiphyseal Dysplasia Tarda, X-Linked1CTD_human
TgeneC4551479Schwartz-Jampel Syndrome, Type 11CTD_human
TgeneC4722327PROSTATE CANCER, HEREDITARY, 11CTD_human